Atrial High-Rate Episode Duration Thresholds and Thromboembolic Risk: A Systematic Review and Meta-Analysis

被引:26
作者
Sagris, Dimitrios [1 ]
Georgiopoulos, Georgios [2 ]
Pateras, Konstantinos [3 ]
Perlepe, Kalliopi [1 ]
Korompoki, Eleni [4 ]
Milionis, Haralampos [5 ]
Tsiachris, Dimitrios [6 ,7 ]
Chan, Cheuk [2 ]
Lip, Gregory Y. H. [8 ,9 ,10 ]
Ntaios, George [1 ]
机构
[1] Univ Thessaly, Dept Internal Med, Fac Med, Sch Hlth Sci, Larisa, Greece
[2] Kings Coll London, Sch Biomed Engn & Imaging Sci, London, England
[3] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Biostat & Res Support, Utrecht, Netherlands
[4] Natl & Kapodistrian Univ Athens, Dept Clin Therapeut, Athens, Greece
[5] Univ Hosp Ioannina, Dept Internal Med, Ioannina, Greece
[6] Athens Heart Ctr, Athens Med Ctr, Athens, Greece
[7] Natl & Kapodistrian Univ Athens, Athens Med Sch, Cardiol Dept 1, Athens, Greece
[8] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England
[9] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England
[10] Aalborg Univ, Aalborg Thrombosis Res Unit, Dept Clin Med, Aalborg, Denmark
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2021年 / 10卷 / 22期
关键词
atrial high-rate episode; embolism; implantable device; stroke; FIBRILLATION; STROKE; EVENTS; ANTICOAGULATION; DEFIBRILLATOR; POPULATION; RATIONALE; OUTCOMES; DESIGN;
D O I
10.1161/JAHA.121.022487
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Available evidence supports an association between atrial high-rate episode (AHRE) burden and thromboembolic risk, but the necessary extent and duration of AHREs to increase the thromboembolic risk remain to be defined. The aim of this systematic review and meta-analysis was to identify the thromboembolic risk associated with various AHRE thresholds. Methods and Results We searched PubMed and Scopus until January 9, 2020, for literature reporting AHRE duration and thromboembolic risk in patients with implantable electronic devices. The outcome assessed was stroke or systemic embolism. Risk estimates were reported as hazard ratio (HR) or relative risk alongside 95% CIs. We used the Paule-Mandel estimator, and heterogeneity was calculated with I-2 index. Among 27 studies including 61 919 patients, 23 studies reported rates according to the duration of the longest AHRE and 4 studies reported rates according to the cumulative day-level AHRE duration. In patients with cardiac implantable devices, AHREs lasting >= 30 seconds significantly increased the risk of stroke or systemic embolism (HR, 4.41; 95% CI, 2.32-8.39; I-2, 5.5%), which remained consistent for the thresholds of 5 minutes and 6 and 24 hours. Patients with previous stroke or transient ischemic attack and AHREs lasting >= 2 minutes had a marginally increased risk of recurrent stroke or transient ischemic attack. The risk of stroke or systemic embolism was higher in patients with cumulative AHRE >= 24 hours compared with those of shorter duration or no AHRE (HR, 1.25; 95% CI, 1.04-1.52; I-2, 0%). Conclusions This systematic review and meta-analysis suggests that single AHRE episodes >= 30 seconds and cumulative AHRE duration >= 24 hours are associated with increased risk of stroke or systemic embolism.
引用
收藏
页数:19
相关论文
共 46 条
[1]   How to obtain the P value from a confidence interval [J].
Altman, Douglas G. ;
Bland, J. Martin .
BMJ-BRITISH MEDICAL JOURNAL, 2011, 343
[2]   Early Detection and Treatment of Atrial Arrhythmias Alleviates the Arrhythmic Burden in Paced Patients: The SETAM Study [J].
Amara, Walid ;
Montagnier, Christian ;
Cheggour, Saida ;
Boursier, Michel ;
Gully, Claude ;
Barnay, Claude ;
Georger, Frederic ;
Deplagne, Antoine ;
Fromentin, Stephane ;
Mlotek, Marcin ;
Lazarus, Arnaud ;
Taieb, Jerome .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2017, 40 (05) :527-536
[3]   GRADE guidelines: 3. Rating the quality of evidence [J].
Balshem, Howard ;
Helfand, Mark ;
Schuenemann, Holger J. ;
Oxman, Andrew D. ;
Kunz, Regina ;
Brozek, Jan ;
Vist, Gunn E. ;
Falck-Ytter, Yngve ;
Meerpohl, Joerg ;
Norris, Susan ;
Guyatt, Gordon H. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2011, 64 (04) :401-406
[4]   Incidence and Clinical Significance of New-Onset Device-Detected Atrial Tachyarrhythmia A Meta-Analysis [J].
Belkin, Mark N. ;
Soria, Cesar E. ;
Waldo, Albert L. ;
Borleffs, C. Jan Willem ;
Hayes, David L. ;
Tung, Roderick ;
Singh, Jagmeet P. ;
Upadhyay, Gaurav A. .
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2018, 11 (03)
[5]   Prediction of atrial fibrillation in patients with an implantable cardioverter-defibrillator and heart failure [J].
Bertini, Matteo ;
Borleffs, C. Jan Willem ;
Delgado, Victoria ;
Ng, Arnold C. T. ;
Piers, Sebastiaan R. D. ;
Shanks, Miriam ;
Antoni, M. Louisa ;
Biffi, Mauro ;
Boriani, Giuseppe ;
Schalij, Martin J. ;
Bax, Jeroen J. ;
Van de Veire, Nico R. L. .
EUROPEAN JOURNAL OF HEART FAILURE, 2010, 12 (10) :1101-1110
[6]   Stereotactic radiosurgery for glioblastoma: retrospective analysis [J].
Biswas, Tithi ;
Okunieff, Paul ;
Schell, Michael C. ;
Smudzin, Therese ;
Pilcher, Webster H. ;
Bakos, Robert S. ;
Vates, G. Edward ;
Walter, Kevin A. ;
Wensel, Andrew ;
Korones, David N. ;
Milano, Michael T. .
RADIATION ONCOLOGY, 2009, 4
[7]   Device-detected atrial fibrillation and risk for stroke: an analysis of > 10 000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices) [J].
Boriani, Giuseppe ;
Glotzer, Taya V. ;
Santini, Massimo ;
West, Teena M. ;
De Melis, Mirko ;
Sepsi, Milan ;
Gasparini, Maurizio ;
Lewalter, Thorsten ;
Camm, John A. ;
Singer, Daniel E. .
EUROPEAN HEART JOURNAL, 2014, 35 (08) :508-516
[8]   Presence and Duration of Atrial Fibrillation Detected by Continuous Monitoring: Crucial Implications for the Risk of Thromboembolic Events [J].
Botto, Giovanni L. ;
Padeletti, Luigi ;
Santini, Massimo ;
Capucci, Alessandro ;
Gulizia, Michele ;
Zolezzi, Francesco ;
Favale, Stefano ;
Molon, Giulio ;
Ricci, Renato ;
Biffi, Mauro ;
Russo, Giovanni ;
Vimercati, Marco ;
Corbucci, Giorgio ;
Boriani, Giuseppe .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2009, 20 (03) :241-248
[9]   Atrial fibrillation is under-recognized in chronic heart failure: insights from a heart failure cohort treated with cardiac resynchronization therapy [J].
Caldwell, Jane C. ;
Contractor, Hussain ;
Petkar, Sanjiv ;
Ali, Razwan ;
Clarke, Bernard ;
Garratt, Clifford J. ;
Neyses, Ludwig ;
Mamas, Mamas A. .
EUROPACE, 2009, 11 (10) :1295-1300
[10]   Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers [J].
Capucci, A ;
Santini, M ;
Padeletti, L ;
Gulizia, M ;
Botto, G ;
Boriani, G ;
Ricci, R ;
Favale, S ;
Zolezzi, F ;
Di Belardino, N ;
Molon, G ;
Drago, F ;
Villani, GQ ;
Mazzini, E ;
Vimercati, M ;
Grammatico, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (10) :1913-1920